{{Rsnum
|rsid=1392635
|Chromosome=15
|position=69105686
|Orientation=plus
|GMAF=0.2438
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 7.1 | 35.4 | 57.5
| HCB | 1.5 | 25.7 | 72.8
| JPT | 2.7 | 23.0 | 74.3
| YRI | 15.0 | 51.0 | 34.0
| ASW | 7.0 | 36.8 | 56.1
| CHB | 1.5 | 25.7 | 72.8
| CHD | 4.6 | 32.1 | 63.3
| GIH | 9.9 | 38.6 | 51.5
| LWK | 20.0 | 44.5 | 35.5
| MEX | 6.9 | 32.8 | 60.3
| MKK | 14.7 | 47.4 | 37.8
| TSI | 7.8 | 36.3 | 55.9
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23118302
  |Trait=Lipoprotein-associated phospholipase A2 activity change in response to statin therapy
  |Title=Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapy.
  |RiskAllele=A
  |Pval=2E-6
  |OR=1.70
  |ORtxt=[0.92-2.48] percent increase
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}